Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
17.95
-0.23 (-1.27%)
May 28, 2026, 3:00 PM CST

SHA:688277 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
174.46264.15260.2310.86211.39287.11
Trading Asset Securities
33.6241.65-50.0440.2120.63
Cash & Short-Term Investments
208.08305.8260.2360.9251.59407.74
Cash Growth
-25.07%17.53%-27.90%43.45%-38.30%-43.42%
Accounts Receivable
48.634.7670.9649.6635.3737.52
Other Receivables
11.2610.3412.539.5211.8510.16
Receivables
59.8645.183.4959.1847.2347.68
Inventory
54.3947.2931.6726.2343.837.94
Prepaid Expenses
----2.992.75
Other Current Assets
46.7544.762.6142.4927.811.3
Total Current Assets
369.08442.89437.97488.8373.41507.42
Property, Plant & Equipment
435.14430.39422.67450.35279.47112.35
Long-Term Investments
614.61617.67596.02454.34467.02265.22
Other Intangible Assets
39.8841.9116.3410.286.697.61
Long-Term Accounts Receivable
--8.251.65-3.41
Long-Term Deferred Tax Assets
9.359.1454.1977.878654.16
Long-Term Deferred Charges
21.9315.3232.5413.8519.3820.23
Other Long-Term Assets
153.6157.02123.73122.34174.98308.64
Total Assets
1,6441,7141,6921,6191,4071,279
Accounts Payable
45.9145.7527.8427.7922.529.63
Accrued Expenses
16.2831.5635.6543.1753.7337.83
Short-Term Debt
13.7416.3825.7832.81--
Current Portion of Long-Term Debt
23.0323.1218.1920.683.29-
Current Portion of Leases
--3.944.933.4722.59
Current Income Taxes Payable
2.111.34----
Current Unearned Revenue
26.942.1538.6617.6132.1131.56
Other Current Liabilities
2.263.286.5320.0813.2611.62
Total Current Liabilities
130.22163.58156.6167.04158.38113.23
Long-Term Debt
150.15154.25150.37157.7521.25-
Long-Term Leases
3.473.350.263.7540.4148.17
Long-Term Unearned Revenue
1.211.537.214.3111.820.7
Long-Term Deferred Tax Liabilities
53.5953.6157.8942.2552.3722.56
Other Long-Term Liabilities
112.92112.0139.246.855.186.82
Total Liabilities
451.55488.34411.58381.95289.39211.48
Common Stock
455.99455.99449.39449.39419.85419.85
Additional Paid-In Capital
1,1601,1431,0451,031668.47670.68
Retained Earnings
-781.81-735.36-551.92-467.22-310.83-192.12
Comprehensive Income & Other
323322.47325.47224.81266.2108.54
Total Common Equity
1,1571,1861,2681,2381,0441,007
Minority Interest
35.2439.5212.29-73.8860.62
Shareholders' Equity
1,1921,2261,2801,2381,1181,068
Total Liabilities & Equity
1,6441,7141,6921,6191,4071,279
Total Debt
190.38197.09198.54219.8998.4270.76
Net Cash (Debt)
17.7108.7161.65141.01153.17336.98
Net Cash Growth
-74.52%76.32%-56.28%-7.94%-54.55%-53.24%
Net Cash Per Share
0.040.240.140.320.360.80
Filing Date Shares Outstanding
464.5455.99449.39449.39419.85419.85
Total Common Shares Outstanding
464.5455.99449.39449.39419.85419.85
Working Capital
238.86279.31281.37321.76215.03394.19
Book Value Per Share
2.492.602.822.752.492.40
Tangible Book Value
1,1171,1451,2521,2271,037999.34
Tangible Book Value Per Share
2.402.512.782.732.472.38
Buildings
--364.64360.55132.86-
Machinery
--118.95110.43108.4763.3
Construction In Progress
---10.13--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.